Biofrigas Sweden AB (publ) (XSAT:BIOF)
0.1700
0.00 (0.00%)
At close: Aug 6, 2026
Biofrigas Sweden AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.58 | 2.18 | 8.24 | 7.66 | 16.4 | 9.01 |
Cash & Short-Term Investments | 0.58 | 2.18 | 8.24 | 7.66 | 16.4 | 9.01 |
Cash Growth | -79.41% | -73.57% | 7.51% | -53.27% | 82.00% | 43.25% |
Accounts Receivable | - | 0 | 3.2 | 3.2 | 3.2 | 0 |
Other Receivables | - | 0.68 | 1.33 | 0.44 | 0.33 | 0.59 |
Total Trade Receivables | - | 0.68 | 4.53 | 3.64 | 3.53 | 0.59 |
Other Current Assets | - | 0.28 | 0.28 | 0.29 | 0.26 | 0.21 |
Total Current Assets | 1.36 | 3.14 | 13.05 | 11.59 | 20.18 | 9.81 |
Net Property, Plant & Equipment | - | 3.2 | 0.04 | 0.26 | 0.53 | 0.39 |
Other Intangible Assets | 22 | 21.27 | 20.67 | 17.93 | 14.38 | 12.55 |
Long-Term Investments | 3.2 | 3.2 | 0 | - | - | - |
Total Assets | 26.56 | 27.61 | 33.76 | 29.79 | 35.09 | 22.75 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.73 | 3.49 | 0.76 | 0.59 | 0.49 |
Accrued Expenses | - | 1.3 | 1.63 | 7.56 | 7.32 | 0.55 |
Unearned Revenue | - | 0 | 0.3 | 0 | - | - |
Other Current Liabilities | - | 1.9 | 2.02 | 1 | 0.07 | 0.27 |
Total Current Liabilities | 3.2 | 3.91 | 7.43 | 9.32 | 7.98 | 1.31 |
Other Long-Term Liabilities | - | 3.58 | 1.77 | 0.51 | 0.51 | 0.51 |
Total Long-Term Liabilities | 5.96 | 3.58 | 1.77 | 0.51 | 0.51 | 0.51 |
Total Liabilities | 9.17 | 7.5 | 9.2 | 9.83 | 8.49 | 1.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 25.08 | 25.08 | 15.28 | 3.87 | 3.87 | 3.23 |
Additional Paid-in Capital | - | 54.41 | 57.33 | 54.39 | 54.39 | 42.51 |
Accumulated Other Comprehensive Income | 22 | 21.24 | 20.67 | 17.93 | 14.38 | 12.55 |
Retained Earnings | -29.69 | -80.61 | -68.72 | -56.25 | -46.05 | -37.36 |
Shareholders' Equity | 17.39 | 20.12 | 24.56 | 19.96 | 26.6 | 20.93 |
Total Liabilities & Equity | 26.56 | 27.61 | 33.76 | 29.79 | 35.09 | 22.75 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 0.58 | 2.18 | 8.24 | 7.66 | 16.4 | 9.01 |
Net Cash Growth | -79.41% | -73.57% | 7.51% | -53.27% | 82.00% | 43.25% |
Net Cash Per Share | 0.01 | 0.02 | 0.14 | 0.55 | 1.20 | 0.80 |
Book Value | 17.39 | 20.12 | 24.56 | 19.96 | 26.6 | 20.93 |
Book Value Per Share | 0.23 | 0.21 | 0.43 | 1.44 | 1.94 | 1.86 |
Tangible Book Value | -4.61 | -1.16 | 3.89 | 2.02 | 12.22 | 8.38 |
Tangible Book Value Per Share | -0.06 | -0.01 | 0.07 | 0.15 | 0.89 | 0.75 |